RxDoctor Payments Data

Anabelle Ross

Acute Care · Canon City, CONPI 1346926771

Payments from drug & device makers

$332in general payments, 2019–2025

Across 17 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$131
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$51
  • Sumitomo Pharma America, Inc.$27
  • Novo Nordisk$23
  • Collegium Pharmaceutical, Inc.$20
  • Astellas Pharma US Inc$18
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$332 in reported general payments places this provider in the 55th percentile of 239 acute care providers in Colorado.

See all acute care providers in Colorado

Medicare billing

Part B allowed, 2024
$30,343
Medicare patients
80
Services billed
614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase12$27,647
OzempicSemaglutide21$27,254
TrulicityDulaglutide13$15,132
Tresiba Flextouch U-200Insulin Degludec13$10,651
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,558
SymbicortBudesonide/Formoterol Fumarate24$5,454
Ventolin HfaAlbuterol Sulfate27$1,983
Octreotide Acetate13$1,917
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,691
Omeprazole71$1,341
Albuterol Sulfate HfaAlbuterol Sulfate39$1,152
Diclofenac Sodium20$942
Gabapentin53$637
Hydroxyzine Hcl21$627
Rosuvastatin Calcium49$465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$131$27,64712 claims
Novo NordiskOzempic$23$27,25421 claims
Lilly USA, LLCTrulicity$18$15,13213 claims
AstraZenecaSymbicort$15$5,45424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 239 acute care providers in Colorado.

Other acute care in Canon City

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →